SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
COVID vaccination gives huge boost to post-infection immunity
Fri February 26th - Vaccination is acting as a booster dose for people already enjoying some protection against COVID-19 after exposure to the disease, British scientists reported last night. More
Increased opioid agonist treatment could reduce drug deaths
Fri February 26th - Scaling up the use of opioid agonists could help to reduce drug-related deaths substantially, new international research claims. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Heart drugs may cut dementia risk

Wednesday January 13th, 2010

By Jane Collingwood
Drugs for high blood pressure and heart disease may confer protection against Alzheimer's disease and dementia, researchers reported today.

A team led by Professor Benjamin Wolozin of Boston University, USA, looked at the possible effects of "angiotensin receptor blockers" on risk of Alzheimer's disease and dementia.

They followed 819,491 participants aged 65 or more with cardiovascular disease for four years. All but two per cent were male.

Dementia rates for participants taking angiotensin receptor blockers were 19 per cent lower than for those taking the blood pressure lowering drug lisinopril, and 24 per cent lower than for those on other heart drugs.

Among patients already diagnosed with Alzheimer's disease or dementia, those on angiotensin receptor blockers had a 49 per cent lower risk of admission to a nursing home than those on other heart drugs. Their risk of dying was 17 per cent lower, on average.

The drug's benefits increased on larger doses, and had an additive effect when taken with another type of high blood pressure drug, ACE inhibitors.

On the website of the British Medical Journal, the team conclude: "Angiotensin receptor blockers are associated with a significant reduction in the incidence and progression of Alzheimer's disease and dementia compared with angiotensin converting enzyme inhibitors or other cardiovascular drugs in a predominantly male population."

They add that this "is a particularly important observation that could have a major impact on public health if validated by future studies".

But Dr Colleen Maxwell and Dr David Hogan of the University of Calgary, Canada, warn in an editorial that "further work is needed to verify the usefulness of antihypertensives in general and angiotensin receptor blockers in particular".

Li, N-C. et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. The British Medical Journal, 2010;340:b5465.

Maxwell, C. J. and Hogan, D. B. Antihypertensive agents and prevention of dementia. The British Medical Journal, 2010;340:b5409.

Tags: Brain & Neurology | Geriatric Health | Heart Health | Menís Health | North America | Pharmaceuticals

Printer friendly page Printer friendly page

CATEGORIES